Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Aug 17;14(4):R189.
doi: 10.1186/ar4020.

Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients

Diluk R W Kannangara, Sheena N Ramasamy, Praveen L Indraratna, Sophie L Stocker, Garry G Graham, Graham Jones, Ian Portek, Kenneth M Williams, Richard O Day
Randomized Controlled Trial

Fractional clearance of urate: validation of measurement in spot-urine samples in healthy subjects and gouty patients

Diluk R W Kannangara et al. Arthritis Res Ther. .

Abstract

Introduction: Hyperuricemia is the greatest risk factor for gout and is caused by an overproduction and/or inefficient renal clearance of urate. The fractional renal clearance of urate (FCU, renal clearance of urate/renal clearance of creatinine) has been proposed as a tool to identify subjects who manifest inefficient clearance of urate. The aim of the present studies was to validate the measurement of FCU by using spot-urine samples as a reliable indicator of the efficiency of the kidney to remove urate and to explore its distribution in healthy subjects and gouty patients.

Methods: Timed (spot, 2-hour, 4-hour, 6-hour, 12-hour, and 24-hour) urine collections were used to derive FCU in 12 healthy subjects. FCUs from spot-urine samples were then determined in 13 healthy subjects twice a day, repeated on 3 nonconsecutive days. The effect of allopurinol, probenecid, and the combination on FCU was explored in 11 healthy subjects. FCU was determined in 36 patients with gout being treated with allopurinol. The distribution of FCU was examined in 118 healthy subjects and compared with that from the 36 patients with gout.

Results: No substantive or statistically significant differences were observed between the FCUs derived from spot and 24-hour urine collections. Coefficients of variation (CVs) were both 28%. No significant variation in the spot FCU was obtained either within or between days, with mean intrasubject CV of 16.4%. FCU increased with probenecid (P < 0.05), whereas allopurinol did not change the FCU in healthy or gouty subjects. FCUs of patients with gout were lower than the FCUs of healthy subjects (4.8% versus 6.9%; P < 0.0001).

Conclusions: The present studies indicate that the spot-FCU is a convenient, valid, and reliable indicator of the efficiency of the kidney in removing urate from the blood and thus from tissues. Spot-FCU determinations may provide useful correlates in studies investigating molecular mechanisms underpinning the observed range of efficiencies of the kidneys in clearing urate from the blood.

Trial registration: ACTRN12611000743965.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fractional clearance of urate CU in gouty patients with incrementally increased doses of allopurinol to achieve target concentrations (Study 1D). Mean age (range) was 56 years (17 to 80 years) (n = 22). The number of patients at each dose level is indicated on the graph.
Figure 2
Figure 2
Distribution of fractional clearance of urate in healthy and gouty subjects in the SVH cohort (Part 2).
See this image and copyright information in PMC

References

    1. Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12:223. doi: 10.1186/ar3199. - DOI - PMC - PubMed
    1. Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, Diem G, Pfeiffer KP, Ulmer H. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol. 2008;125:232–239. doi: 10.1016/j.ijcard.2007.11.094. - DOI - PubMed
    1. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63:102–110. doi: 10.1002/acr.20344. - DOI - PMC - PubMed
    1. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005;143:499–516. - PubMed
    1. Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965;8:694–706. doi: 10.1002/art.1780080429. - DOI - PubMed

Publication types